| A |
| ADC |
Accelerated Disease Control Initiatives |
| ADIPs |
Accelerated Development and Introduction Plans |
|
Annual Progress Report |
|
Antigen |
| AD syringes |
Auto-disable syringes |
| return to top |
| B |
|
Birth cohort |
|
Bridge Financing |
|
Buffer stock |
|
BOD |
Burden of disease |
| return to top |
| C |
|
Cold chain |
|
Conjugate vaccine |
|
Country Support Process |
| CVI |
The Children’s Vaccine Initiative |
| return to top |
| D |
| DTP3 |
Three doses of Diphtheria, Tetanus and Pertussis |
| DTaP |
Diphtheria, Tetanus and Acellular Pertussis vaccine |
| DTwP |
Diphtheria, Tetanus, whole cell Pertussis Vaccine |
| DQA |
Data Quality Audit |
| DQS |
Data Quality Self Assessment |
| DCVMN |
Developing Country Vaccine Manufacturers Network |
| return to top |
| E |
|
Eligible country |
| EPI |
Expanded Program on Immunization |
| return to top |
| F |
| FSP |
Financial Sustainability Plan |
|
Front-loaded investment |
| return to top |
| G |
| GAVI |
Global Alliance for Vaccines and Immunization |
|
GAVI Added Value |
|
GAVI Principles |
|
GAVI Strategic Framework |
| GAVI WP |
GAVI Work Plan |
| GIVS |
Global Immunization Vision and Strategy |
| return to top |
| H |
| hep B or HB |
Hepatitis B |
| Hib |
Haemophilus influenzae type b |
| HPV |
Human papillomavirus |
| return to top |
| I |
| ISS |
Immunization services support |
|
Inactivated vaccine |
| INS |
Injection safety |
| ICC |
Inter-agency Coordinating Committee |
| IFF |
International Finance Facility |
| IFFIm |
International Finance Facility for Immunization |
|
IFFIm Co |
| IC |
Investment Case |
| ICF |
Investment Case Framework |
|
Investment Case Guidelines |
| return to top |
| J |
| JE |
Japanese Encephalitis |
| JRF |
Joint Reporting Form |
| return to top |
| L |
|
Live attenuated virus vaccines |
| LICUS |
Low Income Countries under Stress |
|
Lyophilized vaccine |
| return to top |
| M |
| MNT |
Maternal and Neonatal Tetanus |
| MNTE |
Maternal and Neonatal Tetanus Elimination |
| MTEF |
Medium term expenditure framework |
|
Meningococcal A/C conjugate vaccine |
| MVP |
The Meningitis Vaccine Project |
| MDGs |
Millennium Development Goals |
|
Monodose |
|
Monovalent vaccine |
| MYP |
Multi Year Plan for Immunization |
| return to top |
| N |
| NIDs |
National Immunization Days |
| return to top |
| P |
|
Pentavalent vaccine |
|
Performance based grants |
|
Phase 1 |
|
Phase 2 |
|
Pneumo ADIP |
| PRSC |
Poverty Reduction Strategy Credits |
| PRSP |
Poverty reduction strategy paper |
|
Pull mechanisms |
|
Push mechanisms |
| return to top |
| R |
| Hib RAT |
Hib Rapid Assessment Tool |
| RED |
Reach Every District |
| RVP |
Rotavirus Vaccine Program |
| return to top |
| S |
|
Safety boxes |
| SWAp |
Sector Wide Approach |
|
“Shares” |
|
Stockpile |
| SIA |
Supplemental Immunization Activities |
| SWB |
System-wide barriers |
| return to top |
| T |
|
Tetravalent |
| return to top |
| U |
|
Under-used Vaccines |
|
Universal Childhood Immunization |
|
Uni-jectTM |
|
User fees |
|
|
| return to top |
| V |
| VFTA or TA |
Vaccine Fund Trust Account at UNICEF (sometimes referred to as UNICEF Trust Account) |
| VF or TVF |
The Vaccine Fund |
| VPD |
Vaccine Preventable Diseases |
| VPP |
Vaccine Provision Project |
| VVM |
Vaccine vial monitors |
| return to top |
| Y |
| YF |
Yellow Fever |
| return to top |
